Seeing Is Believing
Currently out of the existing stock ratings of David Maris, 48 are a BUY (50%), 38 are a HOLD (39.58%), 10 are a SELL (10.42%).
Analyst David Maris, carries an average stock price target met ratio of 44.57% that have a potential upside of 19.84% achieved within 275 days. Previously, David Maris worked at WELLS FARGO, BMO.
David Maris’s has documented 201 price targets and ratings displayed on 20 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on TEVA, Teva Pharma Industries Ltd ADR at 28-Oct-2021.
Analyst best performing recommendations are on SIEN (SIENTRA).
The best stock recommendation documented was for TEVA (TEVA PHARMA INDUSTRIES LTD ADR) at 10/28/2021. The price target of $10 was fulfilled within 5 days with a profit of $1.27 (14.55%) receiving and performance score of 29.1.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 21-Dec-2016
$193
$-0.02 (-0.01%)
6 years 5 months 6 days ago
(21-Apr-2020)
2/8 (25%)
$8.96 (4.87%)
125
Hold Since 08-May-2019
$203
$9.98 (5.17%)
$178
6 years 7 months 17 days ago
(10-Feb-2020)
5/19 (26.32%)
$4.87 (2.46%)
74
Buy Since 03-Aug-2017
$198
$4.98 (2.58%)
$188
6 years 8 months 5 days ago
(22-Jan-2020)
3/12 (25%)
$7.8 (4.10%)
176
$203
$9.98 (5.17%)
$189
6 years 10 months 8 days ago
(19-Nov-2019)
1/2 (50%)
$19.19 (10.44%)
96
Buy Since 03-Aug-2015
$200
6 years 10 months 8 days ago
(19-Nov-2019)
2/12 (16.67%)
$73.92 (58.63%)
290